ClinicalTrials.Veeva

Menu

31P Magnetic Resonance Spectroscopy Fructose Study (31PMRS_FRU)

S

Stephen Bawden

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: Fructose

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02217605
A32006_FRU

Details and patient eligibility

About

The purpose of this study is to determine the effects of an oral fructose challenge on liver adenosine triphosphate (ATP) reserves using 31P magnetic resonance spectroscopy (MRS) as a potential measure measure of liver health.

Full description

This study uses 31P spectra acquired from the liver in healthy subjects following a fructose drink to monitor ATP levels. This is also related to baseline BMI, liver glycogen and liver lipid levels

Enrollment

10 patients

Sex

Male

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male
  • Age 18 - 30
  • BMI 20 - 27 kg/m^2
  • Healthy

Exclusion criteria

  • Smokers
  • Liver disease or Metabolic Disorders
  • Metal implants (not suitable for MRI)

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Fructose
Experimental group
Description:
Oral Fructose Challenge (75 g fructose in 500 ml water) followed by 75 minutes 31P MRS
Treatment:
Dietary Supplement: Fructose

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems